Refalgin

CE medical device with a mechanical action, in the form of swallowable film-coated tablets with rapid gastric dissolution.
Tablets based on alginate derived from sea algae, indicated for the treatment of gastric reflux in order to reduce related symptoms. It can be used during continuous treatment with non-steroidal anti-inflammatory drugs as primary prophylaxis for NSAID gastropathy.

Ingredients
Alginic acid 365 mg; sodium alginate 300 mg; calcium carbonate; maltodextrin; sodium chloride; microcrystalline cellulose; silicon dioxide; simethicone; hydrogenated vegetable fat; magnesium stearate; water; film coating: hydroxypropylcellulose.

Instructions for use
Swallow 1 - 2 tablets after meals with a little water.
Wash your hands before and after using the medical device.
The duration of use depends on the evolution of symptoms; if necessary, Refalgin tablets can be taken for prolonged periods.

Warnings
Do not use in case of individual hypersensitivity to any of the product's components.
The safety of use during pregnancy and breastfeeding has not been demonstrated. In such circumstances, it is advisable to consult your doctor.
No interactions with other products are known, therefore it is advisable to consult your doctor before using Refalgin tablets in combination with other medical devices or drugs.
Keep out of reach and sight of children.

Storage
Store the product tightly closed in a cool, dry place.

Format
Pack of 20 tablets, 1.3 g each.

CE mark registration number
0373